83674 Results

People

  1. Ladanyi
    Ladanyi
  2. Larson
    Larson
  3. Wolchok
    Wolchok
  4. Scher
    Scher
  5. DeMatteo
    DeMatteo
  6. Offit
    Offit
  7. Motzer
    Motzer
  8. Zelenetz
    Zelenetz
  9. O'Reilly
    O'Reilly
  10. Gonen
    Gonen

Groups

  1. GSK Faculty (16350)
  2. Surgery (15907)
  3. Sloan Kettering Institute Faculty (14815)
  4. Solid Tumor Oncology Division (14739)
  5. Survivorship Research (10666)
  6. Center for Hematologic Malignancies (9180)
  7. Population Sciences Research Program (8474)
  8. Sloan Kettering Institute Postdocs (7124)
  9. Molecular Pharmacology and Chemistry Program Faculty (6814)
  10. Epidemiology and Biostatistics (6726)
Refine Results
Formats
  1. Journal Article (54833)
  2. Meeting Abstract (23330)
  3. Book Section (4072)
  4. Conference Paper (1148)
  5. Book Whole (291)
Groups
  1. GSK Faculty (16350)
  2. Surgery (15907)
  3. Sloan Kettering Institute Faculty (14815)
  4. Solid Tumor Oncology Division (14739)
  5. Survivorship Research (10666)
  6. Center for Hematologic Malignancies (9180)

More Groups

People
  1. Victor Reuter (1084)
  2. Marc Ladanyi (1063)
  3. Howard Scher (987)
  4. Robert Motzer (950)
  5. Murray Brennan (927)
  6. David Klimstra (922)

More People

Years
  1. 2021 (3)
  2. 2020 (3011)
  3. 2019 (5164)
  4. 2018 (5179)
  5. 2017 (4891)
  6. 2016 (4741)

More Years

Publications
  1. Journal of Clinical Oncology (5991)
  2. Blood (3338)
  3. Cancer Research (2139)
  4. International Journal of Radiation Oncology, Biology, Physics (1873)
  5. Modern Pathology (1563)
  6. Laboratory Investigation (1464)

More Publications

Publishers
  1. Elsevier Inc. (9344)
  2. American Society of Clinical Oncology (6288)
  3. Nature Publishing Group (6167)
  4. Springer (5200)
  5. American Association for Cancer Research (4566)
  6. Elsevier Science, Inc. (4228)

More Publishers

Results (83674)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Embolotherapy for the management of liver malignancies other than hepatocellular carcinoma
    Book Section

    Boas, F. E.; Sofocleous, C. T.
    In Mauro, M. A.; Murphy, K. P.; Thomson, K. R.; Venbrux, A. C.; Morgan, R. A. (Eds.) Image-Guided Interventions. 3rd ed (2021)

    Fulltext@MSK | Save
  • Management of malignant biliary tract obstruction
    Book Section

    Thornton, R. H.; Covey, A. M.
    In Mauro, M. A.; Murphy, K. P.; Thomson, K. R.; Venbrux, A. C.; Morgan, R. A. (Eds.) Image-Guided Interventions. 3rd ed (2021)

    Fulltext@MSK | Save
  • Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?
    Journal Article

    Plodkowski, A. J.; Araujo-Filho, J. A. B.; Simmers, C. D. A.; Girshman, J.; Raj, M.; Zheng, J.; Rimner, A.; Ginsberg, M. S.
    Clinical Imaging (2021)

    Fulltext@MSK | Save
  • Integrin-mediated mechano-transduction controls HER2 oncogenic signaling and activation of YAP in breast cancer
    Meeting Abstract

    Wang, S.; Kim, Y. M.; Garippa, R.; Norton, L.; Giancotti, F. G.
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Incidence of seizure and associated risk factors in patients in the medical intensive care unit (ICU) at Memorial Sloan Kettering Cancer Center (MSKCC) in 2016-2017
    Meeting Abstract

    Azary, S.; Caravanos, C.; Reiner, A.; Panageas, K.; Dhawan, V.; Avila, E.
    Neurology (2020)

    Fulltext@MSK | Save
  • Pilot study of glucarpidase in combination with rituximab and methotrexate (MTX) in CNS lymphoma (CNSL)
    Meeting Abstract

    Schaff, L.; Sener, U.; Gavrilovic, I.; Miller, A.; Stone, J.; Skakodub, A.; Madzsar, J.; Schumpp, A.; Acosta, E.; Lobbous, M.; more...
    Neurology (2020)

    Fulltext@MSK | Save
  • NeuroBytes: A new rapid, high-yield, nationwide e-Learning platform for continuing professional development in neurology
    Meeting Abstract

    Lavette, L.; Miller, A.; London, Z.; Santini, V.; Ruff, I.; Kraakevik, J.; Chamberlain, A.; Rogers-Baggett, B.; Cook, C.; Merkler, A.; more...
    Neurology (2020)

    Fulltext@MSK | Save
  • EV-301: A phase 3 study evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial cancer (la/mUC) who have progressed on platinum-containing chemotherapy or anti-PD-(L)1 therapy
    Meeting Abstract

    Petrylak, D.; Rosenberg, J.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E.; Melhem-Bertrandt, A.; Powles, T.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Patient safety alert: Medical image manipulation as a safety hazard for wrongsite procedures
    Meeting Abstract

    Taylor, J. S.; Bailin, P. L.; Vidimos, A. T.; Lucas, J.; Vij, A.; Halpern, A. C.; Dennison, D. K.
    Journal of Investigative Dermatology (2020)

    Fulltext@MSK | Save
  • The EV-103 Trial: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for patients with locally advanced or metastatic urothelial cancer
    Meeting Abstract

    Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Melhem-Bertrandt, A.; Flaig, T. W.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save